Luque et al. have described multiple structures of human alpha-2-macroglobulin (A2M) determined from samples purified from frozen human plasma (1). The authors interpreted two of these structures (Protein Data Bank [PDB] entries 7O7M and 7O7L) as native A2M, i.e., representative of A2M in its original, physiological state before proteolysis and with an intact thiol ester (TE). The other structures are proposed to represent intermediate or final states occurring during A2M’s proteolysis-induced conformational change. However, there are significant differences between the two putatively native A2M structures and other determined structures of native proteins in the A2M family (A2MF), including complement factor C3 (2), A2M-like protein 1 (A2ML1) (3), and ovomacroglobulin (A2Moo) from the frog Xenopus laevis (4). In these proteins, the TE is protected in a hydrophobic environment formed by the TE and macroglobulin 8 (MG8) domains. In particular, two highly conserved MG8 tyrosine residues (Fig. 1 A and B) are arranged in a nearly identical fashion around the TE and restrict its access to water. This arrangement is not present in the 7O7M and 7O7L entries, where the MG8 tyrosines are positioned far from the TE, exposing it to solvent (Fig. 1C). Furthermore, the distance between the Cys972 Sγ and Gln975 Cδ atoms is 3.4 to 5.5 Å in these two entries, which is inconsistent with the expected ∼1.7-Å bond length of a TE. Considering these differences alongside the otherwise high degree of similarity in A2MF proteins’ structures and function, it is unlikely that the 7O7M and 7O7L structures are representative of A2M’s native structure. Possibly, they are conformational intermediates of A2M with hydrolyzed TEs; similar intermediates have been observed for complement C3 (5).
Approximately 75% of A2M molecules in the samples were not native according to the authors, and this percentage increases if the 7O7M and 7O7L structures are also nonnative. In contrast, the typical percentage of nonnative A2M in circulation is less than 1% (6), as nonnative A2M is rapidly cleared from circulation in the liver (7). Using well-established purification protocols that do not separate A2M’s conformational states, homogeneously native A2M (as determined by pore-limited native polyacrylamide gel electrophoresis and LRP1 binding) can be purified from fresh plasma (8). Therefore, it seems likely that the A2M samples used by Luque et al. (1) were damaged in some way. Freezing has been shown to alter the structure and functionality of A2M (9) and other A2MF proteins such as complement C3 (10). The A2M samples used by Luque et al. (1) were purified from frozen plasma, which may explain the sample heterogeneity, the low content of native A2M, and the probably nonnative 7O7M and 7O7L structures.
Acknowledgments
This study was supported by the VELUX FONDEN (00014557), the Danish Council for Independent Research-Medical Science (DFF-4004-00471), the LEO Foundation, and the Novo Nordisk Foundation (BIO-MS) (NNF18OC0032724).
Footnotes
The authors declare no competing interest.
References
- 1.Luque D., et al. , Cryo–EM structures show the mechanistic basis of pan-peptidase inhibition by human α2-macroglobulin. Proc. Natl. Acad. Sci. U.S.A. 119, 10.1073/pnas.2200102119 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Janssen B. J., et al. , Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 437, 505–511 (2005). [DOI] [PubMed] [Google Scholar]
- 3.Nielsen N. S., et al. , Cryo-EM structures of human A2ML1 elucidate the protease-inhibitory mechanism of the A2M family. Nat. Commun. 13, 3033 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Arimura Y., Funabiki H., Structural mechanics of the alpha-2-macroglobulin transformation. J. Mol. Biol. 434, 167413 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Pangburn M. K., Spontaneous reformation of the intramolecular thioester in complement protein C3 and low temperature capture of a conformational intermediate capable of reformation. J. Biol. Chem. 267, 8584–8590 (1992). [PubMed] [Google Scholar]
- 6.Zucker S., Lysik R. M., Zarrabi M. H., Fiore J. J., Strickland D. K., Proteinase-alpha 2 macroglobulin complexes are not increased in plasma of patients with cancer. Int. J. Cancer 48, 399–403 (1991). [DOI] [PubMed] [Google Scholar]
- 7.Imber M. J., Pizzo S. V., Clearance and binding of two electrophoretic “fast” forms of human alpha 2-macroglobulin. J. Biol. Chem. 256, 8134–8139 (1981). [PubMed] [Google Scholar]
- 8.Harwood S. L., et al. , Substituting the thiol ester of human A2M or C3 with a disulfide produces native proteins with altered proteolysis-induced conformational changes. Biochemistry 59, 4799–4809 (2020). [DOI] [PubMed] [Google Scholar]
- 9.Wyatt A. R., Kumita J. R., Farrawell N. E., Dobson C. M., Wilson M. R., Alpha-2-macroglobulin is acutely sensitive to freezing and lyophilization: Implications for structural and functional studies. PLoS One 10, e0130036 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Pangburn M. K., A fluorimetric assay for native C3. The hemolytically active form of the third component of human complement. J. Immunol. Methods 102, 7–14 (1987). [DOI] [PubMed] [Google Scholar]